期刊文献+

高免疫原性骨桥蛋白的构建、表达及鉴定

Construction and expression of high immunogenic osteopontin fusion proteins
原文传递
导出
摘要 目的重组及表达高免疫原性骨桥蛋白(OPN)的融合蛋白。方法使用Lasergene软件分析OPN基因,选取出免疫原性高的区域作为目的片段。提取总RNA,应用逆转录、PCR等技术扩增OPN基因目的片段,将其分别与带有His标签的pET-32a及GST标签的pGEX-4T-1载体连接。构建表达载体,诱导表达OPN融合蛋白(分别含有His,GST—Tag),并进行SDS—PAGE及Western blotting鉴定。结果扩增后获得一条351bp的DNA片段,经测序鉴定为目的片段序列,并实现了可溶性高表达,经Western blotting鉴定为高免疫原性OPN融合蛋白。结论采用原核表达经纯化后可获得高纯度高免疫原性的OPN融合蛋白,为进一步开发OPN诊断试剂打下基础。 Objective To clone and express osteopontin(OPN)fusion proteins with high immunogenic-ity. Methods OPN gene was analyzed using Lasergene software, and a high immunogenic region was selected as target fragment. The fragment of the target gene was cloned by RT-PCR from total RNA, The amplified gene was inserted into vectors pET-32a and pGEX-4T-1. The recombinant plasmids were constructed and expressed proteins (including His-Tag and GST-Tag, respectively) were identified by SDS-PAGE and Western blotting. Results A DNA band about 351 bp was confirmed as target OPN fragment by DNA sequencing. Sohlble ex-pression of high immunogenic OPN fusion proteins was achieved, which was identified by Western blotting. Con-clusion High immunogenic OPN fusion proteins with high purity have been expressed successfully in prokary-otic system. The study lays a foundation for further development of OPN diagnostic reagent.
出处 《国际免疫学杂志》 CAS 2013年第6期480-484,共5页 International Journal of Immunology
基金 哈尔滨市科技创新人才研究专项资金项目(2008RFXXS018)
关键词 骨桥蛋白 肝癌 高免疫原性区 Osteopontin Hepatocellular carcinomas High immunogenic region
  • 相关文献

参考文献15

  • 1Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin ,2005,55 ( 2 ) :74-108.
  • 2Jemal A, Center MM, DeSantis C, et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Bio- markers Prey ,2010,19 ( 8 ) : 1893-1907.
  • 3Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin,2011,61 (2) :69-90.
  • 4Lopez JB. Recent developments in the first detection of hepatocel- lular carcinoma. Clin B ioehem Rev,2005,26 (3) :65-79.
  • 5Hagym6si K, Tulassay Z. Epidemiology, risk factors and molecular pathogenesis of primary liver cancer. Orv Hetil,2008,149 (12) : 541-548.
  • 6Marrero JA, Henley KS. The role of serum biomarkers in hepatocel- lular carcinoma surveillance. Gastroenterol Hepatol (N Y) ,2011,7 (12) : 821-823.
  • 7王嘉倍,刘连新.肝细胞癌生物标志物的研究进展[J].世界华人消化杂志,2005,13(18):2251-2256. 被引量:34
  • 8Oldberg A, Franzn A, Heineg rd D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly- Asp cell-binding sequence. Proc Natl Acad Sci U S A, 1986,83 (23) : 8819-8823.
  • 9Rangaswami H, Bulbule A, Kundu GC. Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol,2006,16 (2) : 79 -87.
  • 10Young MF,Kerr JM,Termi'ne JD,et al. cDNA cloning,mRNA distri- bution and heterogeneity,chromosomal location,and RFLP analysis of human osteopontin ( OPN ). Genomics, 1990,7"(4) :491-502.

二级参考文献4

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部